Transgene Biotek Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

-6.01

-10.40

-10.43

-10.96

-8.79

Net cashflow-operating activity

-

0.10

0.01

0.14

-1.74

Net cash used in investing activity

-0.01

-0.10

-0.04

-

1.74

Netcash used in fin. activity

-

-

-

-0.20

-

Net inc/dec in cash and equivlnt

-0.01

-

-0.02

-0.06

-

Cash and equivalnt begin of year

0.02

0.01

0.04

0.10

0.10

Cash and equivalnt end of year

-

0.02

0.01

0.04

0.10